Copertina

Effective communication and public engagement strategies to counter misinformation about infectious diseases

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Sheena Cruickshank, Martin McKee, Christina Pagel
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Immunology & Cell Biology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Highlights of 2024: Tregs immunometabolism and how to counter inflammatory niches
di: Nicolas Valentini, et al.
Pubblicazione: (2025)

Renewing an author‐centric publication process
di: Adrian Liston
Pubblicazione: (2024)

Immunology in Practice: a modular framework to support Master of Science students conference attendance and engagement
di: Malgorzata Trela, et al.
Pubblicazione: (2024)

Choose your own T‐cell fate: creation of a narrative‐based, decision‐making activity to engage students in immunology
di: Helen E Ritchie, et al.
Pubblicazione: (2024)

Type I interferon: it's all about intracellular TLR4
di: Harald Husebye
Pubblicazione: (2025)

Gamma‐irradiated Newcastle disease virus: an alternative inactivated oncolytic virotherapy
di: Eve V Kennedy, et al.
Pubblicazione: (2026)

Indigenous student engagement in science: a case study addressing the lack of diversity and equity in biomedical science and pharmacy research for Aboriginal and Torres Strait islander people
di: Wukul Yabang, et al.
Pubblicazione: (2025)

Origins and drivers of self‐reactive B cells in autoimmune disease
di: Adrian Y S Lee, et al.
Pubblicazione: (2026)

Targeting glutamine metabolism in CD4+ T‐cell‐mediated autoimmune diseases
di: Zheng Li, et al.
Pubblicazione: (2025)

Are single nucleotide polymorphisms underutilized for guiding treatment of inflammatory bowel disease?
di: Jildou van der Werf, et al.
Pubblicazione: (2025)

The new Flemings now sing: a methodological evaluation of gamification and citizen science strategies to raise awareness on antimicrobial resistance
di: Antonio Tarín‐Pelló, et al.
Pubblicazione: (2026)

Highlights of 2024: The rising role of age‐associated B cells in autoimmune diseases
di: Adrian YS Lee, et al.
Pubblicazione: (2025)

Functional immune profiling reveals CD4 + T cell dysregulation in coeliac disease
di: Anthony J Farchione, et al.
Pubblicazione: (2026)

Self‐reactive B cells are increased in all major stages of peripheral development in Sjögren's disease
di: Adrian YS Lee, et al.
Pubblicazione: (2025)

Targeting JAK–STAT signaling for autoimmune diseases: current understanding, clinical advances, and emerging directions
di: Zhimin Wu, et al.
Pubblicazione: (2026)

Transcriptomic signatures of host immune responses in aphthous ulcers, the earliest lesions of Crohn's disease, suggest that bacterial uptake, rather than global dysbiosis, is the initiating factor
di: Phillip J Whiley, et al.
Pubblicazione: (2025)

Affinity alone does not drive long‐lived plasma cell differentiation
di: Courtney E McDougal, et al.
Pubblicazione: (2024)

Microbe‐responsive human γδ T cells: the peculiar case of Staphylococcus aureus
di: Matthias Eberl, et al.
Pubblicazione: (2025)

Sex‐dimorphic gene regulation in murine macrophages across niches
di: Cassandra J McGill, et al.
Pubblicazione: (2025)

Auto‐inducible expression of chimeric antigen receptor T cells using the NR4A1 promoter
di: Samuel WJ Smith‐Bell, et al.
Pubblicazione: (2026)

Academic leadership careers are not limited to scientific research
di: Jessica G Borger, et al.
Pubblicazione: (2025)

Antigen specificity, not tissue compartment, determines clonal sharing among respiratory tract CD8 + resident memory T cells
di: Thi H O Nguyen, et al.
Pubblicazione: (2026)

IL‐2 silencing enables Tfh cell expansion during vaccination but is redundant for antibody production
di: Silvia Innocentin, et al.
Pubblicazione: (2026)

The role of peripheral serotonin in SARS ‐ CoV ‐2 infectivity, COVID ‐19 treatment and long COVID
di: Daniel W Thorpe, et al.
Pubblicazione: (2026)

Cytosolic delivery of bacterial metabolites by riboflavin transporters promotes MR1 antigen presentation and MAIT cell recognition
di: Sebastian Cruz‐Gomez, et al.
Pubblicazione: (2026)

Characterization of the MT‐2 Treg‐like cell line in the presence and absence of forkhead box P3 (FOXP3)
di: Morgan J McCullough, et al.
Pubblicazione: (2024)

The immune checkpoint TIGIT is upregulated on T cells during bacterial infection and is a potential target for immunotherapy
di: Timothy R McCulloch, et al.
Pubblicazione: (2024)

Identification of metabolically activated macrophages in human adipose tissue and their possible role in preadipocyte differentiation
di: Elena Berenice Martínez‐Shio, et al.
Pubblicazione: (2026)

Humoral epitope dominance and immune imprinting by SARS ‐ CoV ‐1 and SARS ‐ CoV ‐2 vaccines
di: Deborah L Burnett, et al.
Pubblicazione: (2026)

A new method to measure cell metabolism of rare cells in vivo reveals a high oxidative phosphorylation dependence of lung T cells
di: Aristeidis Roubanis, et al.
Pubblicazione: (2025)

Th17 cells in cancer: plasticity‐driven immunopathology and therapeutic opportunity
di: Henry Sutanto, et al.
Pubblicazione: (2025)

Highlights of 2024: Cytokines and ligands modulating NK cell effector functions
di: Aneena Mary Shajan, et al.
Pubblicazione: (2025)

Highlights of 2024. Broadening anti‐cancer immunotherapy modalities with antibody–drug conjugates: emerging insights from clinical studies
di: Jiya Jose, et al.
Pubblicazione: (2025)

Sketching T cell atlases in the single‐cell era: challenges and recommendations
di: Itana Bojović, et al.
Pubblicazione: (2025)

Delta inulin alone or combined with CpG oligonucleotide enhances antibody‐dependent influenza vaccine protection in mice and nonhuman primate newborns
di: Isaac G Sakala, et al.
Pubblicazione: (2025)

Breaking down barriers with sensory science—improving accessibility to neuroimmunology for the blind and low‐vision communities
di: Stavroula Piliou, et al.
Pubblicazione: (2025)

Tyro3 deletion is protective in experimental autoimmune encephalomyelitis
di: Michele D Binder, et al.
Pubblicazione: (2025)

Phase 2 randomized controlled trial of seasonal influenza vaccine shows Advax® delta inulin adjuvant accelerates the humoral anti‐influenza response
di: Lei Li, et al.
Pubblicazione: (2025)

Modeling the response to interleukin‐21 to inform natural killer cell immunotherapy
di: Indrani Nayak, et al.
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2025)